Little pouches of nicotine sold by the brand ZYN were given the green light for marketing this week through the U.S. Food and ...

Radiopharmaceuticals company Telix Pharmaceuticals has provided its Q4 FY24 trading update, showing sustained revenue growth.

The Food and Drug Administration (FDA) announced on Thursday that it authorized the marketing of Zyn nicotine pouches but ...

The authorization means pouches can be marketed to adults 21 or older but doesn’t mean the products are “FDA approved.” ...

The U.S. Food and Drug Administration on Thursday okayed the marketing of 20 Zyn nicotine pouch products after undertaking an ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has received a positive decision ...

The FDA authorized the marketing of 20 different Zyn nicotine pouch products -- the first brand to clear this regulatory ...

The Food and Drug Administration issued marketing granted orders to 20 Zyn nicotine pouch products. The announcement on ...

The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by ...

Geron Corporation's RYTELO gains FDA approval for Low-Risk MDS, with strong sales projections and promising Phase 3 study.

The Food and Drug Administration authorized the marketing of 20 Zyn nicotine pouch products through the premarket tobacco product application ...

Tobacco stocks gained slightly on Thursday after the FDA has authorized the marketing of 20 Zyn nicotine pouch products ...